GLENMARK PHARMACEUTICALS
|
The Current P/S Ratio of GLENMARK PHARMACEUTICALS is 4.21.
Share Price | ₹1,990.6 | Sep 04,2025 |
Market Cap | ₹56,174.7 Cr | |
Sales-TTM | ₹13,342.0 Cr | TTM-Consolidated Results |
Price/Sales | 4.21x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLENMARK PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹56,174.7 Cr] as on Sep 04,2025
(/) Sales [ ₹13,342.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.21x ]
Thus, for GLENMARK PHARMACEUTICALS , the investors are currently willing to pay '4.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLENMARK PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLENMARK PHARMACEUTICALS
PS Ratio Performance Analysis for GLENMARK PHARMACEUTICALS
- GLENMARK PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.78x.
- GLENMARK PHARMACEUTICALS 's operated at median p/e ratio of 1.2x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 3.26x.
- GLENMARK PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 1.01x.
How does GLENMARK PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLENMARK PHARMACEUTICALS | 13,342.0 | 4.21 | 56,174.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.06 | 379,659.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.88 | 162,886.0 |
CIPLA LTD | 27,811.2 | 4.58 | 127,435.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.28 | 121,719.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.12 | 104,610.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.18 | 105,918.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.31 | 101,831.0 |
LUPIN LTD | 23,375.9 | 3.79 | 88,583.0 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.88 | 60,127.5 |
ABBOTT INDIA LTD | 6,589.9 | 10.38 | 68,417.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.88x |
Max industry PS | 16.88x |
Median industry PS | 4.58x |
Average industry PS | 6.79x |
You may also like the below Video Courses